Oncologic - Use of botulinum toxins in cancer therapy

被引:35
作者
Ansiaux, Reginald [1 ]
Gallez, Bernard [1 ]
机构
[1] Dept Pharmaceut Sci, Biomed Magnet Resonance Unit, B-1200 Brussels, Belgium
关键词
chemotherapy; oxygenation; perfusion; radiotherapy; tumour microenvironment;
D O I
10.1517/13543784.16.2.209
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A recent study has demonstrated for the first time that botulinum neurotoxin (BoNT) briefly opens tumour vessels, allowing more effective destruction of cancer cells by radiotherapy and chemotherapy. This review discusses the implications of BoNTs in cancer treatment. After briefly reviewing the different BoNT serotypes, their pharmacological activities and their general use in medicine, the authors focus on their possible application in cancer and describe how BoNTs have been used so far to treat spasm related to tumour or to therapies. By dissecting the mechanisms of action leading to a potentiation of anticancer therapy, it can be seen that BoNTs act by an effect on the tumour microenvironment rather than by a direct cytotoxic effect on tumour cells.
引用
收藏
页码:209 / 218
页数:10
相关论文
共 81 条
[1]   Botulinum toxin potentiates cancer radiotherapy and chemotherapy [J].
Ansiaux, R ;
Baudelet, C ;
Cron, GO ;
Segers, J ;
Dessy, C ;
Martinive, P ;
De Wever, J ;
Verrax, J ;
Wauthier, V ;
Beghein, N ;
Grégoire, V ;
Calderon, PB ;
Feron, O ;
Gallez, B .
CLINICAL CANCER RESEARCH, 2006, 12 (04) :1276-1283
[2]  
Ansiaux R, 2005, CLIN CANCER RES, V11, P743
[3]   Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions [J].
Aoki, KR ;
Guyer, B .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 :21-29
[4]   A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice [J].
Aoki, KR .
TOXICON, 2001, 39 (12) :1815-1820
[5]  
ASHTON AC, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P191
[6]   How does blood oxygen level-dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? [J].
Baudelet, C ;
Gallez, B .
MAGNETIC RESONANCE IN MEDICINE, 2002, 48 (06) :980-986
[7]   Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia? [J].
Baudelet, C ;
Ansiaux, R ;
Jordan, BF ;
Havaux, X ;
Macq, B ;
Gallez, B .
PHYSICS IN MEDICINE AND BIOLOGY, 2004, 49 (15) :3389-3411
[8]   MIBG inhibits respiration: Potential for radio- and hyperthermic sensitization [J].
Biaglow, JE ;
Manevich, Y ;
Leeper, D ;
Chance, B ;
Dewhirst, MW ;
Jenkins, WT ;
Tuttle, SW ;
Wroblewski, K ;
Glickson, JD ;
Stevens, C ;
Evans, SM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04) :871-876
[9]   Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy [J].
Birch, JF ;
Varma, SK ;
Narula, AA .
BRITISH JOURNAL OF PLASTIC SURGERY, 1999, 52 (03) :230-231
[10]   INTERACTION OF I-125 LABELED BOTULINUM NEUROTOXINS WITH NERVE-TERMINALS .1. ULTRASTRUCTURAL AUTORADIOGRAPHIC LOCALIZATION AND QUANTITATION OF DISTINCT MEMBRANE ACCEPTORS FOR TYPE-A AND TYPE-B ON MOTOR NERVES [J].
BLACK, JD ;
DOLLY, JO .
JOURNAL OF CELL BIOLOGY, 1986, 103 (02) :521-534